Your sourcing partner for pharmaceutical solutions 

  • Specialized product portfolio
  • Technical support
  • Regulatory support

Our Portfolio

Antifoams

Silicone Tubing

APIs & Excipients

Excipients for topical and oral applications like skin protectants, carriers, rheological modifiers, sweeteners, humectants, fillers, binders and disintegrants.

Our Portfolio

Active
pharmaceutical
ingredients

Excipients

Nutraceuticals

Our Services

Offer

› Product
portfolio
› REACH & GDP
compliance

Excipients

› Technical

› Regulatory

› Formulation development

› Laboratory

Relations

› Long-term partnerships

› Global sourcing network

› Transparency

Spotlight

GDP compliant

News and Press

Our partners

Laboratory, formulation and project support

Our Portfolio

Silicone tubing

Antifoams

APIs & Excipients

Biopharmaceutical Process

Process Aids & Equipment available for Pharmaceutical Production Processes

Antifoam solutions

Ultra pure fluid transport

Extractables Particulates Bioburden

Silicone tubing

Our Services

Learn more

Relations

  • Long-term partnerships
  • Global sourcing network
  • Transparency

Support

  • Specialised  product portfolio
  •  Technical  consultation
  • Project support

Quality

  • Regulatory  support
  • GDP certification
  • Compendial and  GMP compliant materials

Biopharmaceutical Process

Process Aids & Equipment available for
Pharmaceutical Production Processes

Antifoam solutions

Ultra pure fluid transport

Extractables Particulates Bioburden

Silicone tubing

Spotlight

Learn more

Support

› Specialised

  product portfolio

› Technical
  consultation
› Project support

Quality

› Regulatory support
› GDP certification
› Compendial and
  GMP compliant
  materials

Relations

› Long-term
  partnerships
› Global sourcing
  network
› Transparency

www.biesterfeld.com

healthcare@biesterfeld.com

Technical consultation

Portfolio

First class suppliers

Go to article: Home | Unpacking innovation in biologics Go to article: In this issueGo to article: ContentsGo to article: MyonexGo to article: Controlant Company InsightGo to article: ControlantGo to article: SHL MedicalGo to article: LabcorpGo to article: ReutersGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: TQS Integration Company InsightGo to article: TQS IntergrationGo to article: Biesterfeld Go to article: CommentGo to article: Biotech and China: a global opportunityGo to article: Intranasal ketamine could effectively treat phantom painGo to article: EU biosimilar wave slows as biosimilar approvals decrease in the EUGo to article: Biosynth Carbosynth Company InsightGo to article: Biosynth CarbosynthGo to article:  Molnár-Institute Company Insight Go to article: Molnar-InstituteGo to article: SkyepharmaGo to article: In DepthGo to article: Unpacking the complex challenge of biologicsGo to article: Living medicines: using bacteria to fight cancerGo to article: The marred history of HIV vaccine trialsGo to article: Has Covid-19 exposed the weakness of the US pharma supply chain?Go to article: How the pandemic pushed pharmacovigilance to innovateGo to article: ExeVir: the llama-derived antibody that could fight Covid-19Go to article: BEA TechnologiesGo to article: WatlowGo to article: DuojectGo to article: ButterworthGo to article: In DataGo to article: Data: Big Data hiring efforts in pharmaGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue